Correlation Between Sonnet Biotherapeutics and Propanc Biopharma

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Propanc Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Propanc Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Propanc Biopharma, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Propanc Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Propanc Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Propanc Biopharma.

Diversification Opportunities for Sonnet Biotherapeutics and Propanc Biopharma

0.0

Correlation Coefficient

Sonnet Biotherapeutics  Propanc Biopharma

Pay attention - limited upside

The 3 months correlation between Sonnet and Propanc is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Propanc Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Propanc Biopharma and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Propanc Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Propanc Biopharma has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Propanc Biopharma go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Propanc Biopharma

If you would invest (100.00) in Propanc Biopharma on September 5, 2024 and sell it today you would earn a total of  100.00  from holding Propanc Biopharma or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  Propanc Biopharma

Sonnet Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sonnet Biotherapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Propanc Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Propanc Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, Propanc Biopharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Sonnet Biotherapeutics and Propanc Biopharma

The main advantage of trading using opposite Sonnet Biotherapeutics and Propanc Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Propanc Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Propanc Biopharma will offset losses from the drop in Propanc Biopharma's long position.

The idea behind Sonnet Biotherapeutics Holdings and Propanc Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.